Background: Mesalamine, an anti-inflammatory drug, is a first-line drug used in the treatment of ulcerative colitis. The premature release of drugs associated with the marketed formulations causes side effects like gastric trouble, nausea, vomiting, diarrhea, etc. These systemic side effects can be minimized by ensuring the site-specific and local delivery of the drug to the colon. Also, the pharmacotherapeutic role of the gut microbiome has a significant impact on the remission of ulcerative colitis. These probiotics being acid-labile necessitates developing a gastro-resistant formulation that can enhance the delivery of viable cells at the site of inflammation. Aim and Objectives: The present study was aimed at developing colon-targeted hydrogel beads loaded with mesalamine and Bifidobacterium bifidum for their synergistic role in the long-term management of ulcerative colitis. This co-encapsulated formulation is target specific, increases the residence time of the drug in the colon due to mucoadhesiveness, sustains the release profile, and significantly enhances the cell viability for better colonization in the colonic mucosa. Methods: The mesalamine and Bifidobacterium bifidum loaded hydrogel beads were prepared by ionotropic gelation. The effect of single and dual cross-linking approach on various formulation characteristics was studied. Eudragit ® S100 gastro-resistant capsules were prepared in standard size 00. The optimised formulation was filled inside the Eudragit ® capsules. Results There was no potential interaction between the drug and the polymer, confirmed through FTIR analysis. The mean particle size, angle of repose, percentage yield, drug entrapment efficiency, percentage drug loading, cell entrapment efficiency, swelling index, mucoadhesiveness, disintegration time (for capsules), and in vitro dissolution profile of the optimized formulation was found to be 457.3±12.5µm, 25.51±0.57, 98.75±0.6%, 98.4±2.56%, 49.8±0.64%, 81.03±2.57%, 10.41±2.02, 83.1±3.62, 12 minutes 46 seconds and 99.85±1.07% (in 20 hours) respectively. All the values were statistically significant at p<0.05. Conclusion: The results strongly supported the aim of the study that prepared hydrogel beads can release mesalamine at colonic pH in a sustained manner while significantly increasing the delivery of viable cells to the colon.